openPR Logo
Press release

Bovine Respiratory Disease Treatment Market is Projected to Expand at a Strong Pace in Terms of Revenue in the Coming Years

09-04-2018 08:15 AM CET | Health & Medicine

Press release from: Transparency Market Research

Bovine Respiratory Disease Treatment Market is Projected

Bovine respiratory disease (BRD) refers to a commonly occurring respiratory disorder amongst cattle that might result from a single or a many number of factors combined. The disease has been gaining much traction lately as it substantially impacts the world beef industry. As a consequence, the treatment as well as prevention of bovine respiratory disease is essential in a bid to mitigate its impact on animal production and the overall beef industry.

Obtain Report Details @ https://www.transparencymarketresearch.com/bovine-respiratory-disease-treatment-market.html

Virbac Group, Vetoquinol, Boehringer Ingelheim GmbH, Bayer AG, Bimeda Animal Health, Zoetis Services LLC, Merck & Co., Inc., Ceva, and Elanco are some of the topnotch companies in this space. Despite the fact that there exist a large number of market players that are operating in the world bovine respiratory disease treatment market, the vendor landscape is regarded as highly consolidated and this has led to a high degree of competition.

In accordance with the research report on the world market for Bovine Respiratory Disease Treatment by Transparency Market Research (TMR), it has been anticipated that strong growth would prevail in the said market. Transparency Market Research figures out that the international market for bovine respiratory disease treatment will expand from US$ 805.9 mn in the year 2015 to US$ 1543.9 mn by 2024, and expected to expand at a CAGR of 7.6% therein.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13700

Asia Pacific is Estimated to Continue with a High Growth Raate Over the Period of Forecast

The world market for bovine respiratory disease treatment has been regionally segmented into the geographies of South America, North America, Asia Pacific, Middle East and Africa, and Europe. From a the geographical point of view, North America which held around 37% of the said market in the year 2015, is estimated to dominate the world market and is anticipated to easily retain its dominance over the forecast period as well. However, due to the population of cattle and the rising incidences of bovine respiratory diseases, the region of Asia Pacific is anticipated to emerge as one of the very lucrative regional markets for the methods of bovine respiratory disease treatment.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13700

Increased Population of Cattle to Encourage Growth of the Market

Of all the key factors that is driving the said market, the increasing consumption of beef is estimated to have much impact on the overall development of the market over the period of forecast. As bovine respiratory diseases account for around 65% to 80% of morbidity and 45% to 75% mortality rate amongst livestock animals, the growing population of cattle will also bolster the need for effective treatment modalities for these diseases. This is forecasted to have a significant positive impact on the world market for bovine respiratory disease treatment.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bovine Respiratory Disease Treatment Market is Projected to Expand at a Strong Pace in Terms of Revenue in the Coming Years here

News-ID: 1217839 • Views:

More Releases from Transparency Market Research

Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
In 2022, the worldwide 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 garnered a valuation of US$ 382.5 billion. Projections indicate a steady growth trajectory, with a compound annual growth rate (CAGR) of 13.1% anticipated from 2023 to 2031, ultimately culminating in a total valuation of US$ 1.1 trillion by the conclusion of 2031. Market analysts foresee a promising outlook characterized by the burgeoning prevalence of chronic diseases and the increasing adoption of smartphones and internet
Global Data Center Networking Market Set to Surge, Forecasted to Reach US$ 56.3 …
The Data Center Networking Market is poised for remarkable growth, driven by the burgeoning demand for cloud-native applications and the rapid adoption of data center virtualization and cloud computing. With an estimated value of US$20.6 billion in 2021, the market is projected to surge at a robust CAGR of 10.8% from 2022 to 2031, reaching a staggering US$56.3 billion by the end of 2031. Get Sample Copy of This Report at:

All 5 Releases


More Releases for Bovine

Bovine Pericardial ValveMarket Size, Share, Development by 2024
Global Info Research offers a latest published report on Bovine Pericardial ValveMarket Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Bovine Pericardial Valveplayers, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Bovine Pericardial Valvewith respect to individual growth
Bovine Blood Plasma Derivatives
Increasing use of bovine blood plasma derivatives in biopharmaceutical companies for cell culture technique, biotechnology, and research and development is expected to drive the market growth. For Instance, in November 2018, Wageningen University initiated the preclinical trial for Bovine plasma protein powder to assess the protein digestion kinetics and protection of the epithelial barriers including other markers for identification of gastrointestinal health, metabolic health, and vascular health, and satiating properties.
Fetal Bovine Serum Market Technology Trends in Future
MarketResearchReports.Biz adds “Global Fetal Bovine Serum Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Fetal Bovine Serum and the growth estimates for the forecasted period. This report studies the Fetal Bovine Serum market, Fetal bovine serum (FBS) or fetal calf serum (spelled foetal in Commonwealth English) is the blood fraction remaining after the natural coagulation of blood, followed
Fetal Bovine Serum Market Research Report | Forecast 2024
Fetal bovine serum, a by-product of the beef industry, is a critical raw material for animal health, biotechnology, diagnostic, and the pharmaceutical industry along with several research areas, as it is a safe and effective growth medium for most of the experimental procedures. Blood from cattle fetus is centrifuged to remove the RBCs (red blood cells). The fraction that remains after natural coagulation of blood is fetal bovine serum. In
Bovine Rennet Market Growing at a Healthy Rate
Global Bovine Rennet Market: Overview Enzyme complex produced in the stomach of bovine is known as bovine rennet. Rennet separates milk into solid curds and is used in liquid whey and for making cheese. Rennet contains enzymes including chymosin, lipase, and pepsin. Vegetarian rennet is a major substitute for bovine rennet and is derived from sources such as wild thistles, safflower, fig leaves, melons, and microorganisms. The North America bovine rennet
Fetal Bovine Serum Market: Analysis & Trends 2024
Fetal bovine serum, a by-product of the beef industry, is a critical raw material for animal health, biotechnology, diagnostic, and the pharmaceutical industry along with several research areas, as it is a safe and effective growth medium for most of the experimental procedures. Blood from cattle fetus is centrifuged to remove the RBCs (red blood cells). The fraction that remains after natural coagulation of blood is fetal bovine serum. In